Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Sep;28(3):257–261. doi: 10.1111/j.1365-2125.1989.tb05424.x

A comparison of the effects of human alpha calcitonin gene-related peptide and glyceryl trinitrate on regional blood velocity in man.

N J MacDonald 1, L Butters 1, D J O'Shaughnessy 1, A J Riddell 1, P C Rubin 1
PMCID: PMC1379942  PMID: 2528983

Abstract

1. Human alpha calcitonin gene-related peptide (h alpha CGRP) is a potent vasodilator which in doses up to 1.5 micrograms min-1 i.v. produces little or no fall in blood pressure in normal volunteers, but does cause a substantial tachycardia. 2. We have explored the underlying mechanism of this effect by comparing h alpha CGRP infused so as to maintain heart rate 25-30% above baseline with glyceryl trinitrate (GTN) in a dose sufficient to maintain a throbbing headache. 3. Ten normal volunteers were studied. In addition to blood pressure and heart rate, blood velocity and pulsatility index (PI) were determined from Doppler signals recorded from the internal and external carotid, renal and femoral arteries. 4. Following h alpha CGRP blood pressure (mean +/- s.d., mm Hg) did not significantly change: 120 +/- 10/70 +/- 7 before compared with 121 +/- 12/67 +/- 7 during h alpha CGRP infusion. Heart rate (mean +/- s.d., beats min-1) increased from 62 +/- 8 to 86 +/- 10 (P less than 0.0001). In contrast the blood pressure fell following GTN: 124 +/- 12/74 +/- 8 before compared with 111 +/- 13/62 +/- 6 following treatment (P less than 0.02). Heart rate did not change following GTN: 64 +/- 9 compared with 69 +/- 10. 5. GTN significantly increased PI (mean +/- s.d.) in the common carotid artery from 2.8 +/- 0.5 to 3.4 +/- 0.5 (P less than 0.003) while h alpha CGRP increased PI in the internal carotid from 1.3 +/- 0.2 to 2.1 +/- 0.4 (P less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brain S. D., Williams T. J., Tippins J. R., Morris H. R., MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 1985 Jan 3;313(5997):54–56. doi: 10.1038/313054a0. [DOI] [PubMed] [Google Scholar]
  2. Deshmukh V. D., Harper A. M. The effect of serotonin on cerebral and extracerebral blood flow with possible implications in migraine. Acta Neurol Scand. 1973;49(5):649–658. doi: 10.1111/j.1600-0404.1973.tb01337.x. [DOI] [PubMed] [Google Scholar]
  3. Fisher L. A., Kikkawa D. O., Rivier J. E., Amara S. G., Evans R. M., Rosenfeld M. G., Vale W. W., Brown M. R. Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide. Nature. 1983 Oct 6;305(5934):534–536. doi: 10.1038/305534a0. [DOI] [PubMed] [Google Scholar]
  4. Gerthoffer W. T., Shafer P. G., Taylor S. Selectivity of phenytoin and dihydropyridine calcium channel blockers for relaxation of the basilar artery. J Cardiovasc Pharmacol. 1987 Jul;10(1):9–15. doi: 10.1097/00005344-198707000-00002. [DOI] [PubMed] [Google Scholar]
  5. Gosling R. G., King D. H. Arterial assessment by Doppler-shift ultrasound. Proc R Soc Med. 1974 Jun;67(6 Pt 1):447–449. [PMC free article] [PubMed] [Google Scholar]
  6. Haass M., Skofitsch G. Cardiovascular effects of calcitonin gene-related peptide in the pithed rat: comparison with substance P. Life Sci. 1985 Dec 2;37(22):2085–2090. doi: 10.1016/0024-3205(85)90580-6. [DOI] [PubMed] [Google Scholar]
  7. Howden C. W., Logue C., Gavin K., Collie L., Rubin P. C. Haemodynamic effects of intravenous human calcitonin-gene-related peptide in man. Clin Sci (Lond) 1988 Apr;74(4):413–418. doi: 10.1042/cs0740413. [DOI] [PubMed] [Google Scholar]
  8. Jacobs J. W., Goodman R. H., Chin W. W., Dee P. C., Habener J. F., Bell N. H., Potts J. T., Jr Calcitonin messenger RNA encodes multiple polypeptides in a single precursor. Science. 1981 Jul 24;213(4506):457–459. doi: 10.1126/science.6264603. [DOI] [PubMed] [Google Scholar]
  9. Kubota M., Moseley J. M., Butera L., Dusting G. J., MacDonald P. S., Martin T. J. Calcitonin gene-related peptide stimulates cyclic AMP formation in rat aortic smooth muscle cells. Biochem Biophys Res Commun. 1985 Oct 15;132(1):88–94. doi: 10.1016/0006-291x(85)90992-1. [DOI] [PubMed] [Google Scholar]
  10. McEwan J., Larkin S., Davies G., Chierchia S., Brown M., Stevenson J., MacIntyre I., Maseri A. Calcitonin gene-related peptide: a potent dilator of human epicardial coronary arteries. Circulation. 1986 Dec;74(6):1243–1247. doi: 10.1161/01.cir.74.6.1243. [DOI] [PubMed] [Google Scholar]
  11. Mulderry P. K., Ghatei M. A., Rodrigo J., Allen J. M., Rosenfeld M. G., Polak J. M., Bloom S. R. Calcitonin gene-related peptide in cardiovascular tissues of the rat. Neuroscience. 1985 Mar;14(3):947–954. doi: 10.1016/0306-4522(85)90156-3. [DOI] [PubMed] [Google Scholar]
  12. Steenbergh P. H., Höppener J. W., Zandberg J., Lips C. J., Jansz H. S. A second human calcitonin/CGRP gene. FEBS Lett. 1985 Apr 22;183(2):403–407. doi: 10.1016/0014-5793(85)80820-6. [DOI] [PubMed] [Google Scholar]
  13. Struthers A. D., Brown M. J., Macdonald D. W., Beacham J. L., Stevenson J. C., Morris H. R., MacIntyre I. Human calcitonin gene related peptide: a potent endogenous vasodilator in man. Clin Sci (Lond) 1986 Apr;70(4):389–393. doi: 10.1042/cs0700389. [DOI] [PubMed] [Google Scholar]
  14. Thom S. M., Hughes A. D., Goldberg P., Martin G., Schachter M., Sever P. S. The actions of calcitonin gene related peptide and vasoactive intestinal peptide as vasodilators in man in vivo and in vitro. Br J Clin Pharmacol. 1987 Aug;24(2):139–144. doi: 10.1111/j.1365-2125.1987.tb03154.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Trudinger B. J., Cook C. M., Giles W. B., Connelly A., Thompson R. S. Umbilical artery flow velocity waveforms in high-risk pregnancy. Randomised controlled trial. Lancet. 1987 Jan 24;1(8526):188–190. doi: 10.1016/s0140-6736(87)90003-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES